Diapharm Analytics extends its BtM license to include cannabis
Diapharm - A Tentamus Company
(PresseBox) - The GMP-certified contract laboratory Diapharm Analytics has expanded its narcotics license to include cannabis. In the future, we can offer our customers the analytics according to the current DAB monograph ?Cannabis Flos?. These are the analytical parameters of identity, content and purity. The specifications of the Ph. Eur. Monograph ?herbal drugs? including the analysis of pesticides, heavy metals, aflatoxins and microbiological purity can also be investigated.
The medical cannabis market is undergoing rapid changes. Worldwide regulatory changes and numerous new developments in medical cannabis products are leading to a growing need for highly professional services. Diapharm, the leading consultant and service provider for strategic solutions, regulatory and QM tasks, and the laboratory Diapharm Analytics, a Tentamus company, are happy to support you in the realization of your cannabis projects.
As a member of the Tentamus Group, Diapharm Analytics offers an all-round service in cooperation with our partner laboratories. These include:
Cannabis flos
batch release testing
Stability studies
Clinical studies
New Formulations of cannabis flos:
Method development and method validation
Analysis and monitoring of product development
Stability studies
Clinical studies
In the run-up, Diapharm can provide strategic, regulatory and QM consulting. We can prepare all documents and manage all necessary processes to establish our clients as importers (2001/83/EC Art. 40 et seqq.) and/or wholesale distributors (Art. 76 et seqq.) with a licence pursuant to the German Narcotic Drugs Act (BTMG) for medical cannabis. Contact us!
Tentamus Group GmbH
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrochemicals, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 50 locations worldwide. More than 2,500 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group
An der Industriebahn 5
13088 Berlin, Germany
www.tentamus.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Tentamus Group GmbHTentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food&feed, pharmaceuticals&medical, agrochemicals, cosmetics, agriculture&environment and nutraceutical&supplements). Tentamus Group is represented in over 50 locations worldwide. More than 2,500 highly-trained staff members work in over 1 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.Tentamus GroupAn der Industriebahn 513088 Berlin, Germanywww.tentamus.com
Datum: 25.03.2019 - 05:05 Uhr
Sprache: Deutsch
News-ID 1547924
Anzahl Zeichen: 2663
contact information:
Contact person:
Town:
Oldenburg
Phone:
Kategorie:
Energy & Utilities
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 886 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Diapharm Analytics extends its BtM license to include cannabis
"
steht unter der journalistisch-redaktionellen Verantwortung von
Tentamus Group GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
